REGENERATION
+ STRUCTURE
BioFiller Australia protocol by Alocuro provides technology & training for clinicians to prepare an injectable ‘biogel’ prepared solely from the patient’s own blood components.
The autologous ‘biogel’ can deliver both cellular rejuvenation from platelets & plasma gel volume to support the skin.
Prepared individually for each patient, created and injected in a single appointment, BioFiller Australia protocol by Alocuro provides unique platelet & plasma processing technology
![HP Final Biofiller - B&A - THoA 2025 G[100].png](https://images.squarespace-cdn.com/content/v1/644dd19c49a74b0b9d27bc9f/21d6a1c8-57c0-4767-945b-c3c7e8d988a3/HP+Final+Biofiller+-+B%26A+-+THoA+2025+G%5B100%5D.png)
![HP Final Biofiller - B&A - THoA 2025 E[83].png](https://images.squarespace-cdn.com/content/v1/644dd19c49a74b0b9d27bc9f/d4639372-7aa4-4f2b-80b5-a9d45212cca4/HP+Final+Biofiller+-+B%26A+-+THoA+2025+E%5B83%5D.png)
Why Clinicians Choose BioFiller by Alocuro Protocol
Start offering BioFiller with the confidence of an established protocol, validated over 5 years by Australian clinicians and supported by 1-on-1 training in your clinic
Exclusive Alocuro protocol. Specialised technology. Comprehensive clinician training.
Looking to introduce BioFiller procedures into your practice?
The BioFiller Australia Protocol provides doctors and nurses access to an established autologous plasma gel preparation technique, supported by Alocuro's specialised platelet-concentrating technology, dedicated training modules and ongoing clinical support.
Launched in 2022 and validated across five years of clinical application and protocol evaluation, commencing with Alocuro’s BioFiller protocol includes technology + preparation methodology, training and practical education needed to successfully implement the technique into clinical practice.
From Blood to BioFiller
01 / COLLECT
Depending on the Alocuro system configuration, 15–30 mL of blood is collected using Alocuro-supplied consumables. Blood is transferred to Alocuro Pro-PRP ARTG-listed, sterile, platelet-concentrating devices.
02 / CONCENTRATE
Using an Alocuro centrifuge & patented protocol, the plasma and platelets are isolated from the remaining blood cells. As the platelets become visible with Alocuro processing, these can be precisely collected within a very small volume of plasma, leaving the remainder of plasma volume to be collected for creating ‘plasma albumin gel’.
03 / PROCESS
The platelet-poor plasma undergoes controlled processing over 14 minutes to create the viscous plasma-albumin-gel, structural component of BioFiller injectate.
04 / COMBINE
Plasma-albumin-gel is combined with high-platelet-dose, liquid PRP to create ‘BioFiller’ according to BioFiller Australia established protocol, and is ready for injection in the same appointment, within less than 30 minutes of blood collection.
DUAL BENEFITS FROM
BIOFILLER AUSTRALIA PROTOCOL
STRUCTURE
Plasma-albumin-gel provides the structural component of BioFiller, and works as a scaffold material below the skin. Made from the patient’s own blood plasma, it provides 4-6 months of volume for suitable patients & where clinically indicated. Published clinical studies of autologous plasma gel have reported improvements in facial volume, skin density and contour, including reductions in nasolabial fold depth. BioFiller gives clinicians an autologous option for addressing volume loss and structural change without introducing a manufactured filler material.
SKIN REJUVENATION
BioFiller does more than provide temporary volume & structure. The concentrated PRP component introduces a platelet-rich fraction containing biologically active growth factors & proteins to support tissue repair and remodelling processes. Clinical literature reports improvements in skin density, texture and elasticity, with supporting evidence of dermal extracellular matrix renewal and collagen-related tissue changes.
The combination of benefits within a single BioFiller Australia protocol addresses both structural support and skin quality within the same autologous preparation.
BioFiller starts with Alocuro PRP
ALOCURO PRP : collect platelets + plasma
→ BIOFILLER PROCESSING: process PAG to gel
→ FINAL BIOFILLER: mix PAG + liquid platelets
Alternate PRP systems can vary significantly in platelet recovery, concentration capability and protocol reproducibility. BioFiller is built around the Alocuro PRP system so clinicians can confidently begin with a defined, protocol-controlled plasma preparation. With independently verified third-party pathology lab data and standardised preparation protocols, clinicians can work with greater confidence in reproducibility and consistency.
~90% average platelet capture
Up to 9× baseline concentration
Australian pathology lab verified
New to Alocuro? Contact us to explore the complete system
Procedure Insights
-
The BioFiller Australia protocol can only be performed by clinicians with advanced injecting skills, after Alocuro’s BioFiller and PRP training using the Alocuro PRP System.
-
BioFiller may be considered in patients presenting with:
Early signs of skin ageing where tissue quality is a priority
Dermal thinning or reduced elasticity
Patients seeking a biologically derived treatment approach
Adjunctive use within a multimodal aesthetic treatment plan
All applications should be guided by clinical training, anatomical understanding, and individual patient assessment.
-
BioFiller’s procedure typically takes 60-90 minutes.
-
A fine blunt-tip microcannula is used for injections, to minimise discomfort.
-
Patients should expect minimal downtime, with potential temporary redness or swelling that subsides in a few days. Post procedure clinical review at 7 days is recommended to ensure optimal BioFiller placement.
